Key facts
- It has raised $22.9M; the latest was Later Stage VC ($1.1M) in Nov 2024.
- Notable investors include Techstars, ACT (Riyadh), Albo Club, Julien Quintard, Maison Worms — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for AZmed
- ·The full record, as it builds
Funding rounds
No funding rounds for AZmed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AZmed
Developer of a computer-aided diagnosis tool designed to facilitate physicians' workflow. The company's tool leverages artificial intelligence to detect all types of bone lesions on standard radiographs and spot any abnormality such as a fracture on any X-rays, enabling radiologists to reduce errors save time, and focus on value-added tasks.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2018
- Employees
- 99
- Website
- azmed.co/
- Ownership
- Privately Held (backing)
AZmed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AZmed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AZmed in its N-PORT filings yet. We sweep new filings monthly.